Image

Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders

Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders

Recruiting
18-35 years
All
Phase N/A

Powered by AI

Overview

The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.

Description

Participants with (n=50) and without (n=100) a history of mTBI will be recruited. Investigators will study the use of a series of visual endurance tests (tests that require sustained visual responses over a period of time). In addition to developing expected values for these tests, investigators will also after qualitative data about discomfort levels during testing.

Eligibility

Inclusion Criteria:

  • Diagnosis of mTBI within previous 1 to 6 months
  • Distance visual acuity better than or equal to 20/25 in each eye
  • Score \>21 on Convergence Insufficiency Symptom Survey

Exclusion Criteria:

  • Diagnosis of moderate or severe TBI; \> 30-min loss of consciousness
  • Not wearing required refractive error)
  • Disease(s) known to affect oculomotor system (multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, or Parkinson disease)-Manifest strabismus or intraocular injury (evaluated at vision examination)
  • Cognitive delays that may impact testing

Study details
    MTBI - Mild Traumatic Brain Injury

NCT07282691

Salus University

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.